The Cigna Group (CI) exhibits 21.8% gross margins and 8.8% return on invested capital within Health Care (Medical Specialities), balanced against a 6.1x enterprise multiple and 7.3% implied options volatility.
Sustained 21.8% gross profitability converts into 3.3% operating margin and 8.8% ROIC, outpacing sector cost of capital.
ROIC: 8.8% // GM: 21.8%YoY revenue trajectory of +11.2% paired with -3.51% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +11.2% // FCF YLD: -3.51%Altman Z-Score of 2.70 and Piotroski F-Score of 5/9 indicate low near-term refinancing stress.
ALTMAN Z: 2.70 // F-SCORE: 5/9Trading at 13.2x trailing P/E (12.3x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 13.2x // EV/EBITDA: 6.1xOptions market prices a ±7.3% implied move with a 0.66 put/call ratio around $292.00 max pain.
IMPL MOVE: ±7.3% // P/C: 0.66Elevated industry capital intensity and customer concentration in Medical Specialities require continuous execution to defend 2.2% net margins.
NET MARGIN: 2.2% // D/E: 1.17x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for CI & activate live FRED threshold breach alerts.